Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy.

Alessandri G, Coccè V, Pastorino F, Paroni R, Dei Cas M, Restelli F, Pollo B, Gatti L, Tremolada C, Berenzi A, Parati E, Brini AT, Bondiolotti G, Ponzoni M, Pessina A.

J Control Release. 2019 May 28;302:2-18. doi: 10.1016/j.jconrel.2019.03.016. Epub 2019 Mar 16.

PMID:
30890444
2.

Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.

Bonomi A, Coccè V, Cavicchini L, Sisto F, Dossena M, Balzarini P, Portolani N, Ciusani E, Parati E, Alessandri G, Pessina A.

Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1 Suppl):33-41.

PMID:
24046947
3.

Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.

Brini AT, Coccè V, Ferreira LM, Giannasi C, Cossellu G, Giannì AB, Angiero F, Bonomi A, Pascucci L, Falchetti ML, Ciusani E, Bondiolotti G, Sisto F, Alessandri G, Pessina A, Farronato G.

Expert Opin Drug Deliv. 2016 Jun;13(6):789-98. doi: 10.1517/17425247.2016.1167037. Epub 2016 Apr 5.

PMID:
26986001
4.

Long-Lasting Anti-Inflammatory Activity of Human Microfragmented Adipose Tissue.

Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, Cadei M, Soldati G, Pessina A, Parati E, Slevin M, Alessandri G.

Stem Cells Int. 2019 Feb 19;2019:5901479. doi: 10.1155/2019/5901479. eCollection 2019.

5.

Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.

Cocce V, Balducci L, Falchetti ML, Pascucci L, Ciusani E, Brini AT, Sisto F, Piovani G, Alessandri G, Parati E, Cabeza L, Pessina A.

Anticancer Agents Med Chem. 2017 Nov 24;17(11):1578-1585. doi: 10.2174/1871520617666170327113932.

PMID:
28356007
6.

Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.

Bonomi A, Ghezzi E, Pascucci L, Aralla M, Ceserani V, Pettinari L, Coccè V, Guercio A, Alessandri G, Parati E, Brini AT, Zeira O, Pessina A.

Vet J. 2017 May;223:41-47. doi: 10.1016/j.tvjl.2017.05.005. Epub 2017 May 19.

PMID:
28671070
7.

Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.

Pacioni S, D'Alessandris QG, Giannetti S, Morgante L, De Pascalis I, Coccè V, Bonomi A, Pascucci L, Alessandri G, Pessina A, Falchetti ML, Pallini R.

Stem Cell Res Ther. 2015 Oct 6;6:194. doi: 10.1186/s13287-015-0185-z.

8.

Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.

Pessina A, Bonomi A, Coccè V, Invernici G, Navone S, Cavicchini L, Sisto F, Ferrari M, Viganò L, Locatelli A, Ciusani E, Cappelletti G, Cartelli D, Arnaldo C, Parati E, Marfia G, Pallini R, Falchetti ML, Alessandri G.

PLoS One. 2011;6(12):e28321. doi: 10.1371/journal.pone.0028321. Epub 2011 Dec 20.

9.

Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.

Pessina A, Coccè V, Bonomi A, Cavicchini L, Sisto F, Ferrari M, Ciusani E, Navone S, Marfia G, Parati E, Alessandri G.

Anticancer Agents Med Chem. 2013 Mar;13(3):523-30.

PMID:
22931415
10.

Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.

Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G, Pessina A.

J Control Release. 2014 Oct 28;192:262-70. doi: 10.1016/j.jconrel.2014.07.042. Epub 2014 Jul 30.

PMID:
25084218
11.

Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.

Bonomi A, Silini A, Vertua E, Signoroni PB, Coccè V, Cavicchini L, Sisto F, Alessandri G, Pessina A, Parolini O.

Stem Cell Res Ther. 2015 Aug 28;6:155. doi: 10.1186/s13287-015-0140-z.

12.

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.

Pacioni S, D'Alessandris QG, Giannetti S, Morgante L, Coccè V, Bonomi A, Buccarelli M, Pascucci L, Alessandri G, Pessina A, Ricci-Vitiani L, Falchetti ML, Pallini R.

Stem Cell Res Ther. 2017 Mar 9;8(1):53. doi: 10.1186/s13287-017-0516-3.

13.

Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.

Mariotti M, Colognato R, Rimoldi M, Rizzetto M, Sisto F, Cocce V, Bonomi A, Parati E, Alessandri G, Bagnati R, Pessina A.

Anticancer Agents Med Chem. 2015;15(3):400-5.

PMID:
24942547
14.

Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy.

Wang X, Gao J, Ouyang X, Wang J, Sun X, Lv Y.

Int J Nanomedicine. 2018 Sep 7;13:5231-5248. doi: 10.2147/IJN.S167142. eCollection 2018.

15.

Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.

Petrella F, Coccè V, Masia C, Milani M, Salè EO, Alessandri G, Parati E, Sisto F, Pentimalli F, Brini AT, Pessina A, Spaggiari L.

Biomed Pharmacother. 2017 Mar;87:755-758. doi: 10.1016/j.biopha.2017.01.118. Epub 2017 Jan 30.

PMID:
28153512
16.

Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.

Scioli MG, Artuso S, D'Angelo C, Porru M, D'Amico F, Bielli A, Gentile P, Cervelli V, Leonetti C, Orlandi A.

PLoS One. 2018 Sep 7;13(9):e0203426. doi: 10.1371/journal.pone.0203426. eCollection 2018.

17.

Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.

Bonomi A, Steimberg N, Benetti A, Berenzi A, Alessandri G, Pascucci L, Boniotti J, Coccè V, Sordi V, Pessina A, Mazzoleni G.

Hematol Oncol. 2017 Dec;35(4):693-702. doi: 10.1002/hon.2306. Epub 2016 Jun 10.

PMID:
27283119
18.

Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.

Ju C, Sun J, Zi P, Jin X, Zhang C.

J Pharm Sci. 2013 Aug;102(8):2707-17. doi: 10.1002/jps.23649. Epub 2013 Jul 9.

PMID:
23839931
19.

Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.

Bonomi A, Lisini D, Navone SE, Frigerio S, Dossena M, Ciusani E, Rampini P, Marfia G, Coccè V, Cavicchini L, Sisto F, Parati E, Mantegazza R, Rimoldi M, Rizzetto M, Alessandri G, Pessina A.

Cytotherapy. 2015 Mar;17(3):310-9. doi: 10.1016/j.jcyt.2014.09.009. Epub 2014 Oct 28.

PMID:
25457277
20.

Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.

Yao S, Li L, Su XT, Wang K, Lu ZJ, Yuan CZ, Feng JB, Yan S, Kong BH, Song K.

J Exp Clin Cancer Res. 2018 Feb 26;37(1):29. doi: 10.1186/s13046-018-0700-z.

Supplemental Content

Support Center